PX1 Research provides analytical-grade Bronchogen for qualified laboratory research, setting the standard for purity, lot-to-lot consistency, and verification. Every batch undergoes independent ISO 17025 third-party testing to guarantee exact amino acid sequence fidelity and minimal endotoxin presence. Designed for in vitro assays and preclinical models, our compounds ship same-day from domestic US facilities.
PX1 Research provides analytical-grade Bronchogen for qualified laboratory research, setting the standard for purity, lot-to-lot consistency, and verification. Every batch undergoes independent ISO 17025 third-party testing to guarantee exact amino acid sequence fidelity and minimal endotoxin presence. Designed for in vitro assays and preclinical models, our compounds ship same-day from domestic US facilities.
A reliable bronchogen surfactant protein supplier provides high-purity synthetic tetrapeptides (Ala-Glu-Asp-Leu) manufactured under strict analytical standards for laboratory research. Qualified suppliers supply lyophilized research compounds backed by mass spectrometry and high-performance liquid chromatography (HPLC) verification to ensure reproducible experimental results in respiratory biology and extracellular matrix preclinical trials.
When sourcing research peptides, academic and clinical investigators require absolute structural fidelity and full analytical transparency. PX1 Research functions as a premier domestic source, delivering synthesized short-chain peptides directly to institutional laboratories. By managing manufacturing standards and utilizing independent testing facilities, we eliminate batch variability, ensuring that your cell culture and animal tissue assays yield precise, dependable data.
Bronchogen is a synthetic short bioregulatory peptide studied primarily within respiratory pathophysiology, epithelial tissue maintenance, and surfactant protein gene expression. In vitro data indicate that short peptide sequences like Ala-Glu-Asp-Leu can interact with chromatin structures and influence DNA transcription within bronchial and alveolar epithelial cells.
Preclinical studies suggest that Bronchogen administration in animal models modulates the synthesis of pulmonary surfactant proteins, notably Surfactant Protein A (SP-A) and Surfactant Protein C (SP-C). Surfactant proteins play a critical biomechanical role by reducing surface tension at the air-liquid interface within pulmonary alveoli, thereby preventing alveolar collapse during respiration. Research models evaluating chronic inflammatory airway conditions utilize Bronchogen to investigate its potential in suppressing pro-inflammatory cytokine cascades (such as TNF-alpha and IL-6) while promoting alveolar epithelial tissue repair.
Investigating the cellular pathway of Bronchogen involves assessing its capacity to cross nuclear membranes and alter gene expression profiles without relying on large protein transport mechanisms. Laboratories exploring cellular homeostasis utilize our catalog of research peptides to establish baseline controls and comparative response curves across diverse epithelial cell lines.
Bronchogen's primary structure consists of four amino acids: L-alanyl-L-glutamyl-L-aspartyl-L-leucine. Due to its low molecular weight, this peptide exhibits unique physical properties during DNA strand binding interactions. Molecular docking assays and spectrophotometric analyses indicate that short peptide motifs bind directly into the major and minor grooves of double-stranded DNA, exhibiting sequence-specific affinity.
This peptide-DNA strand binding mechanism is hypothesized to induce localized structural alterations in chromatin, enhancing RNA polymerase accessibility to targeted promoter regions. In preclinical gene expression models, Bronchogen's strand binding dynamics are evaluated against control sequences to map histone modifications and transcriptional activation rates. Obtaining stable, highly purified peptide for these biophysical assays requires exact stoichiometry and freedom from counter-ion contamination, which is why sourcing from a verified supplier is essential for quantitative research.
In preclinical inflammation and tissue repair research, Bronchogen is frequently compared against other short-chain signaling peptides and cytoprotective compounds. While Bronchogen specifically targets pulmonary gene expression and bronchial epithelial integrity, compounds such as KPV exhibit broad anti-inflammatory properties by inhibiting NF-kB translocation across multiple mucosal tissues. Understanding these distinct pathways allows researchers to design complementary multi-peptide assays.
Similarly, research evaluating extracellular matrix remodeling and cellular migration often incorporates systemic repair peptides alongside tissue-specific bioregulators. For example, studies investigating overall tissue regeneration frequently compare local alveolar signaling with systemic growth factor cascades triggered by Thymosin Beta-4 or organ-protective peptides like BPC-157. Assessing these compounds in parallel helps clarify whether observed cellular responses stem from localized gene transcription or generalized cytoprotective pathways. Researchers exploring systemic bioregulatory peptides can find detailed documentation in our research library hub.
Selecting an analytical-grade peptide vendor requires evaluating specific technical standards to prevent experimental noise or cell culture toxicity. PX1 Research adheres to rigorous purity metrics across every batch:
• Third-Party COA per Lot: Independent ISO 17025 accredited laboratory verification provided for every production run. • RP-HPLC Purity Verification: Guaranteed minimum purity of 98% (typically ≥99%) to eliminate truncation sequences and side-reaction byproducts. • Mass Spectrometry (MS) Analysis: Electrospray ionization mass spectrometry (ESI-MS) confirming exact theoretical molecular weight. • Endotoxin Testing: Quantified bacterial endotoxin levels (LAL assay) ensuring levels below strict thresholds (<0.01 EU/µg) for sensitive cell assays. • US Manufacturing & Traceability: Domestic production under strict quality control guidelines with complete lot traceability. • Domestic Logistics: Same-day shipping Monday through Friday from facilities in California and Arizona to preserve product integrity.
Investigators inquiring about the bronchogen strand binding price are typically evaluating overall research procurement costs against purity benchmarks and analytical documentation. In academic and corporate laboratory budgets, the true value of a research compound depends on batch consistency, analytical validation, and sequence stability rather than raw milligram price alone. Low-cost unverified peptides often contain TFA salts, residual solvents, or synthesis truncated impurities that skew experimental outcomes and waste valuable cell culture media.
PX1 Research maintains competitive institutional pricing structures while enforcing uncompromising quality controls. For high-throughput screening, multi-plate cellular assays, or institutional procurement, laboratories can utilize our wholesale research accounts to access bulk pricing schedules, custom vial sizing, and dedicated account management. Individual standard research quantities can be sourced directly through our product catalog.
To preserve the structural integrity of synthetic Bronchogen during in vitro testing, research personnel must follow standard aseptic reconstitution procedures. The lyophilized peptide powder should be allowed to equilibrate to room temperature inside a desiccator before opening the vial to prevent atmospheric moisture condensation.
Reconstitution should be performed using Sterile Bacteriostatic Water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of your specific assay. Gentle swiveling of the vial is recommended; high-shear vortexing or vigorous agitation should be avoided as it can induce protein aggregation or mechanical denaturing of short-chain peptide bonds. Once reconstituted, stock solutions should be aliquoted into single-use polypropylene microcentrifuge tubes to prevent repeated freeze-thaw cycles that alter peptide concentration and biological availability.
Proper storage conditions are critical for maintaining peptide stability and preventing hydrolytic degradation over extended experimental timelines. Lyophilized Bronchogen powder should be stored at -20°C in a manual defrost freezer, protected from light exposure. Under these conditions, the un-reconstituted compound remains stable for up to 24 months from the date of synthesis.
Following reconstitution, liquid aliquots intended for use within 24 to 48 hours may be held at 2°C to 8°C. For long-term preservation of stock solutions, aliquots must be stored at -80°C. Researchers evaluating non-pulmonary bioregulatory peptides like Epithalon should note that short peptide chains generally demonstrate superior thermal stability compared to large globular proteins, provided moisture ingress is strictly controlled.
Quantitative research demands absolute confirmation of chemical identity. PX1 Research subjects every batch of Bronchogen to reverse-phase high-performance liquid chromatography (RP-HPLC). The resulting chromatogram verifies peptide purity by confirming that the main peak represents ≥98% of the total integrated peak area, ensuring freedom from deletion peptides or unreacted precursor amino acids.
Mass spectrometry (MS) complements HPLC by confirming the precise molecular mass of the tetrapeptide. Furthermore, because bacterial endotoxins (lipopolysaccharides) alter cellular inflammation responses in preclinical models, our lot-specific testing includes quantitative Chromogenic LAL Assays. Providing these verified metrics ensures that observed cellular changes in your assays stem solely from Bronchogen activity rather than extrinsic contaminants.
Where can I find a verified bronchogen surfactant protein supplier?
PX1 Research is a domestic US supplier providing analytical-grade Bronchogen for laboratory research. Every lot is manufactured under strict quality standards and verified via independent ISO 17025 third-party HPLC and mass spectrometry testing.
How does the bronchogen strand binding price compare across research suppliers?
The cost of Bronchogen for research varies based on batch purity, third-party analytical testing, and endotoxin verification. PX1 Research provides tier-based institutional pricing and wholesale options to ensure cost-effective procurement without sacrificing analytical quality or sequence purity.
Is Bronchogen supplied for human consumption or clinical administration?
No. Bronchogen provided by PX1 Research is strictly designated for laboratory research use, in vitro assays, and preclinical animal models. It is not for human or veterinary use, therapy, diagnosis, or clinical administration.
What analytical documentation accompanies PX1 Research peptides?
Every lot of Bronchogen includes a downloadable, lot-specific Certificate of Analysis (COA) containing RP-HPLC chromatograms, mass spectrometry (MS) spectral analysis, and LAL endotoxin test results.
How should Bronchogen be reconstituted for in vitro assays?
Reconstitute lyophilized Bronchogen using sterile laboratory-grade water or phosphate-buffered saline (PBS, pH 7.4). Gently swirl the solution until completely dissolved; avoid aggressive vortexing to prevent peptide mechanical stress.
What are the recommended storage temperatures for Bronchogen?
Lyophilized powder should be stored at -20°C (or -80°C for long-term storage), desiccation-protected and shielded from light. Reconstituted stock solution aliquots should be frozen at -80°C to avoid degradation from freeze-thaw cycles.
What is the amino acid sequence of Bronchogen?
Bronchogen is a synthetic tetrapeptide with the primary amino acid sequence Ala-Glu-Asp-Leu (L-alanyl-L-glutamyl-L-aspartyl-L-leucine).
What preclinical research models utilize Bronchogen?
Bronchogen is evaluated in preclinical models investigating pulmonary surfactant gene expression (SP-A and SP-C), bronchial epithelial cell repair mechanisms, DNA strand binding kinetics, and anti-inflammatory signaling pathways.
What are PX1 Research's shipping timelines for domestic laboratory orders?
Orders placed Monday through Friday before cut-off times ship same-day from our facilities located in California and Arizona, ensuring rapid delivery to minimize laboratory downtime.
How can institutional laboratories set up a wholesale peptide account?
Institutional buyers and principal investigators can submit an account application through our wholesale portal to establish high-volume laboratory pricing, tailored vial sizing, and scheduled recurring shipments.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.